
1. acg case rep j. 2015 jul 9;2(4):247-9. doi: 10.14309/crj.2015.74. ecollection
2015 jul.

autoimmune hepatitis triggered treatment pegylated interferon α-2a and
ribavirin chronic hepatitis c.

rathi c(1), pipaliya n(1), choksi d(1), parikh p(1), ingle m(1), sawant p(1).

author information: 
(1)department gastroenterology, lokmanya tilak municipal medical college and
general hospital, sion, mumbai, maharashtra, india.

hepatitis flare rarely observed treatment pegylated interferon
alpha hepatitis c virus (hcv) infection. 49-year-old man receiving
pegylated interferon α-2a hcv infection icterus hyperbiliru-binemia
in 14th week therapy, hcv rna undetectable 12th dose. liver
biopsy suggestive chronic hepatitis cirrhosis without interface
pattern. pegylated interferon discontinued; weeks later, his
aminotransferases immunoglobulin levels increased significantly. antibody 
cytosolic liver antigen-1 positive, liver biopsy revealed
lymphoplasmacytic infiltrate intense interface hepatitis, consistent with
autoimmune hepatitis.

doi: 10.14309/crj.2015.74 
pmcid: pmc4508956
pmid: 26203454 

